Si-Bone (SIBN) Long-Term Investments (2019 - 2020)
Si-Bone's (SIBN) quarterly Long-Term Investments came in at $1.3 million in Q1 2020, little changed quarter-over-quarter from $1.3 million in Q4 2019.
Si-Bone (SIBN) Long-Term Investments (2019 - 2020) Analysis & Trends
Si-Bone's Long-Term Investments history runs 2 years deep, the most recent figure standing at $1.3 million for Q1 2020.
- On a quarterly basis, Long-Term Investments changed N/A year-over-year to $1.3 million in Q1 2020; TTM through Mar 2020 was $1.3 million, a N/A change from a year earlier, with the FY2019 full-year figure at $1.3 million, changed N/A from the prior year.
- Long-Term Investments held at $1.3 million in Q1 2020 per SIBN's latest filing, from $1.3 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $5.3 million in Q3 2019 and bottomed at $1.3 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.09 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 285.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 166.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 121.00 Mn |
| 10 | Si-Bone | 724.02 Mn | 579.33 Mn | 41.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 1.27 Mn |
| Dec 31, 2019 | 1.28 Mn |
| Sep 30, 2019 | 5.27 Mn |
| Jun 30, 2019 | 5.26 Mn |